Flavours and fragrances industry: growth holds, margins split

What’s changing in flavours and fragrances industry earnings this quarter

Portfolio reshaping is accelerating across the sector. IFF agreed to divest its Food Ingredients business. Givaudan took a majority stake in Eurofragance and moved into encapsulation technology. Symrise divested its Aqua Feed business and is lining up an acquisition of Floral Concept in premium naturals.

Growth is also splitting geographically. Robertet grew 21% in Latin America and 12% in Asia, but declined 1% in Europe and North America. Symrise saw Asia Pacific grow 12.3% and North America grow 9.6%, while EAME and Latin America both declined.

Margins are where the quarter divides. Sensient and DSM-Firmenich expanded margins through operating leverage, pricing, and cost discipline. Robertet and Givaudan absorbed higher logistics costs tied to Middle East disruption and other non-recurring items. Regulatory change is also becoming a growth driver: Sensient’s natural colour conversion business is being accelerated by the US synthetic Red 3 ban, while IFF, Robertet, and DSM-Firmenich all pointed to R&D investment in biologicals, health and beauty, and perfumery as sources of higher-margin growth.

Three companies worth a closer look

Sensient: Net sales rose 11.6% to €410M in Q2. Operating margin rose 2.7 points to 16.6%, driven by a 20.6% jump in its Color segment as natural colour conversions accelerated, partly pushed by the US synthetic Red 3 ban. Management is guiding toward the company’s €1 billion sales target, with confidence in growth continuing into the second half.

DSM-Firmenich: Delivered 6% like-for-like sales growth to €2,388M in Q2. Perfumery & Beauty grew 7% on strong fine fragrance performance, and adjusted EBITDA margin improved to 19.5%, helped by favourable product mix and early savings from a restructuring programme targeting €100 million in cuts. The company is advancing a €500 million share buyback and guiding FY2026 sales growth toward the higher end of its range.

Givaudan: The quarter’s clearest outlier. H1 sales fell 1.7% to €4,055M, and operating margin contracted 3 points to 16.7%, even as like-for-like sales grew 3.6% and Fragrance & Beauty gained momentum in Consumer Products and Fine Fragrance. Currency strength and cost pressure offset the underlying volume gains, though the company expanded its portfolio through the acquisitions of Belle Aire Creations and Vollmens Fragrances.

Competitor intelligence at earnings speed

This summary covers one quarter across a selection of companies in the flavours and fragrances industry. It brings together, in one aligned view:

• Forward-looking signals and guidance from each company
• A synthesis of the quarter’s main cross-company themes
• Sentiment scoring across five dimensions: revenue development, profit development, market conditions, revenue outlook, and profit outlook
• Company-by-company breakdowns for IFF, Givaudan, DSM-Firmenich, Symrise, Robertet, and Sensient

The Valona platform extends the same structured analysis to each company individually, updated as new earnings and disclosures are published.

Structured, evidence-based analysis, applied the same way across every company and every quarter, turns a recurring disclosure into a dependable input for competitive intelligence rather than one-off commentary built on memory. Learn more about earnings analysis.